two
cardin
manifest
viral
immun
effici
clearanc
acut
infect
capac
vaccin
secondari
viral
exposur
norovirus
contribut
cell
viral
clearanc
vaccin
elucid
report
cell
requir
effici
clearanc
primari
murin
noroviru
mnv
infect
intestin
intestin
lymph
node
longlast
protect
immun
gener
oral
live
viru
vaccin
system
vaccin
mnv
capsid
protein
also
effect
protect
mucos
challeng
vaccin
capsid
protein
distantli
relat
human
lordsdal
viru
provid
partial
protect
fulli
effect
vaccin
requir
broad
immun
respons
includ
cell
cell
b
cell
import
specif
immun
cell
type
vari
intestin
intestin
lymph
node
perforin
interferon
gamma
requir
clearanc
mnv
infect
adopt
transfer
lymphocyt
vaccin
host
studi
prove
feasibl
mucos
system
vaccin
mucos
noroviru
infect
demonstr
tissu
specif
noroviru
immun
cell
indic
effici
vaccin
strategi
induc
potent
cell
respons
epidem
nonbacteri
gastroenter
worldwid
attribut
human
norovirus
hunv
infect
transmit
fecalor
symptomat
infect
character
nausea
vomit
andor
diarrhea
last
hour
within
hour
exposur
despit
signific
cost
morbid
hunv
infect
vaccin
current
avail
elderli
individu
longterm
care
facil
may
suscept
either
noroviru
infect
norovirusinduc
diseas
would
import
target
popul
noroviru
vaccin
reason
increas
incid
suscept
hunv
diseas
unknown
due
part
incomplet
understand
noroviru
immun
potenti
vaccin
relat
virus
demonstr
gnotobiot
piglet
cat
rabbit
immun
mechan
respons
identifi
challeng
vaccin
efficaci
may
differ
differ
calicivirus
exampl
variat
mnv
strain
significantli
less
hunv
strain
human
volunt
studi
demonstr
shortterm
longterm
protect
homolog
heterolog
viral
challeng
sinc
hunv
belong
genogroup
gi
gii
giv
mani
strain
genogroup
lack
crossprotect
challeng
vaccin
develop
frequent
exposur
norovirus
within
short
time
period
stimul
sustain
immun
resist
noroviru
induc
ill
serum
antibodi
level
adult
reflect
suscept
infect
alway
correl
protect
children
howev
serum
antibodi
level
correl
protect
like
reflect
shortterm
immun
recent
exposur
nonfunct
fucosyl
transferas
gene
account
signific
proport
though
resist
norwalk
viru
infect
suggest
factor
yet
undiscov
may
contribut
noroviru
resist
absenc
cell
cultur
system
hunv
viru
like
particl
vlp
assembl
viral
capsid
protein
express
import
evalu
noroviru
immun
respons
studi
use
norwalk
viru
gi
snow
mountain
viru
gii
gii
vlp
evalu
immun
infect
live
viru
immun
vlp
oral
show
product
cell
effector
cytokin
interferon
c
ifnc
prolifer
noroviru
specif
cell
vitro
restimul
vlp
studi
show
cell
respons
develop
defin
role
either
clearanc
primari
infect
resist
rechalleng
togeth
suggest
potenti
vaccin
leav
open
import
question
effect
longev
vaccin
immun
respons
mechan
vaccin
viral
protein
target
protect
respons
potenti
crossprotect
distantli
relat
norovirus
identif
first
murin
noroviru
mnv
propag
cultur
cell
provid
facil
anim
model
studi
noroviru
immun
pathogenesi
mnv
enter
viru
infect
tissu
gastrointestin
tract
spread
fecalor
rout
unpublish
studi
mnv
genom
encod
four
open
read
frame
encod
polyprotein
cleav
individu
nonstructur
protein
similar
polyprotein
hunv
encod
major
capsid
protein
encod
minor
capsid
protein
exist
protein
product
confirm
mnv
virion
structur
capsid
like
human
norovirus
consist
dimer
differ
mnv
virion
previous
report
vlp
structur
mnv
protrud
domain
lift
shell
domain
approxim
angstrom
rotat
approxim
degre
clockwis
fashion
form
interact
base
infecti
virion
observ
previous
exist
novel
aspect
structur
consist
hypothesi
mnv
may
undergo
capsid
matur
process
studi
mnv
pathogenesi
reveal
import
role
interferon
ifn
mediat
innat
immun
resist
infect
mnv
induc
lethal
import
adapt
immun
control
mnv
infect
indic
observ
develop
persist
mnv
infect
wild
type
wt
mice
clear
infect
strain
mnv
mnv
effici
enter
viru
infect
mani
mice
research
mous
coloni
around
world
diarrhea
report
mnv
infect
thu
mnv
provid
infect
model
hunv
infect
viral
titer
tissu
infect
mice
report
exceed
pfuml
highest
level
viral
titer
obtain
infect
highli
suscept
wt
mice
viral
titer
pfuml
routin
observ
avail
plaqu
assay
mnv
allow
analysi
mnv
infect
despit
low
titer
mnv
strain
persist
low
level
wt
mice
other
clear
intestin
spleen
liver
mesenter
lymph
node
mln
fece
within
day
infect
addit
wild
type
mice
mnv
replic
maxim
distal
ileum
comparison
wild
type
mice
replic
occur
proxim
intestin
signific
differ
known
studi
noroviru
infect
human
volunt
specif
investig
whether
infect
spread
beyond
intestin
local
lymph
node
howev
possibl
system
invas
occur
human
chronic
condit
immunosuppress
host
addit
viremia
report
infect
gnotobiot
pig
calv
thu
abil
mnv
spread
tissu
intestin
oral
infect
may
uniqu
relationship
aspect
mnv
pathogenesi
human
infect
clear
avail
strain
clear
wt
mice
provid
opportun
defin
mechan
respons
two
cardin
aspect
viral
immun
capac
effect
clear
acut
infect
immun
mechan
respons
effect
vaccin
b
cell
mnv
specif
antibodi
import
clearanc
primari
mnv
infect
role
cell
clearanc
potenti
mechan
vaccin
mucos
noroviru
challeng
unknown
show
vaccin
either
live
mnv
venezuelan
equin
enceph
replicon
particl
vrp
express
mnv
capsid
protein
protect
intestin
rechalleng
least
six
month
live
viru
effect
vrpmediat
vaccin
partial
cross
protect
mnv
infect
vaccin
hunv
capsid
protein
found
clearanc
primari
infect
vaccin
requir
concert
effort
cell
cell
b
cell
cell
requir
effector
molecul
perforin
maxim
impact
mnv
infect
effect
specif
immun
cell
type
tissu
specif
differ
ileum
mesenter
lymph
node
first
studi
demonstr
immun
mechan
respons
noroviru
clearanc
vaccin
first
determin
whether
could
detect
shortterm
immun
homolog
mnv
challeng
whether
protein
encod
specif
mnv
orf
could
elicit
effect
immun
vrp
express
hunv
lordsdal
genogroup
chiba
genogroup
produc
vaccin
experi
western
blot
vrpinfect
cell
lysat
reveal
protein
appropri
size
addit
show
hyperimmun
polyclon
rabbit
antisera
mnv
crossreact
low
level
vlp
chiba
viru
lordsdal
viru
figur
wt
mice
vaccin
boost
three
week
later
two
week
boost
mice
challeng
organ
titer
mnv
three
day
later
figur
wt
mice
maxim
mnv
replic
intestin
tract
occur
distal
ileum
viral
titer
could
detect
duodenum
jejunum
data
shown
oral
inocul
wt
mice
exhibit
detect
viral
titer
distal
ileum
mln
three
five
day
postinfect
prior
infect
human
norovirus
common
caus
epidem
nonbacteri
gastroenter
world
despit
import
human
pathogen
littl
known
immun
system
control
clear
noroviru
infect
potenti
mechan
vaccin
remain
unclear
use
noroviru
infect
mice
show
vaccin
provid
longlast
immun
mucos
noroviru
challeng
identifi
type
immun
cell
import
vaccin
noroviru
infect
similarli
identifi
type
immun
cell
import
clearanc
acut
infect
effici
vaccin
requir
three
major
arm
adapt
immun
cell
cell
b
cell
importantli
protect
vaccin
mucos
challeng
observ
either
mucos
system
noroviru
antigen
exposur
poreform
molecul
perforin
import
cellmedi
control
noroviru
infect
studi
import
implic
understand
adapt
immun
noroviru
infect
may
provid
insight
direct
take
develop
human
noroviru
vaccin
either
p
p
significantli
decreas
replic
distal
ileum
compar
control
mice
infect
reoviru
figur
similar
decreas
observ
mln
vaccin
p
p
figur
compar
reoviru
control
similar
result
observ
spleen
data
shown
statist
signific
differ
vaccin
demonstr
protect
secondari
immun
respons
develop
clearanc
primari
mnv
infect
vrp
protect
distal
ileum
p
mln
p
compar
control
vrp
express
hemagglutinin
ha
mous
adapt
influenza
viru
ha
vrp
control
group
control
vrp
vaccin
also
includ
pb
ha
vrp
control
significantli
differ
pb
control
across
experi
statist
comparison
vrp
vaccin
therefor
shown
ha
vrp
control
vrp
alon
distal
ileum
distal
ileum
mln
combin
vrp
small
statist
signific
effect
level
figur
vrp
alon
confer
signific
protect
figur
togeth
data
show
vaccin
either
live
viru
vrp
confer
shortterm
protect
mnv
challeng
next
assess
vaccin
heterolog
protein
mice
vaccin
boost
vrp
express
chiba
viru
lordsdal
viru
challeng
vaccin
lordsdal
viru
capsid
led
statist
signific
protect
mnv
infect
distal
ileum
p
figur
mln
figur
signific
reduct
mnv
titer
seen
immun
chiba
viru
capsid
figur
protect
lordsdal
vrp
vaccin
correl
gener
crossreact
serum
igg
mice
measur
elisa
despit
potenti
crossreact
reveal
western
blot
figur
fecal
extract
immun
mice
yield
measur
homotyp
heterotyp
igg
iga
data
shown
taken
togeth
data
show
measur
function
immunolog
cross
protect
lordsdal
viru
mnv
distal
ileum
lack
correl
serum
fecal
antibodi
respons
protect
suggest
protect
may
cell
mediat
sinc
older
adult
may
suscept
younger
adult
noroviru
infect
diseas
determin
whether
increas
age
alter
vaccin
efficaci
prior
work
shown
mice
older
year
age
diminish
vaccin
respons
sar
viru
antigen
therefor
compar
vaccin
efficaci
adult
week
old
age
month
old
mice
adult
age
mice
vaccin
challeng
contrast
studi
use
sar
viru
antigen
age
mice
respond
well
adult
mice
mnv
vaccin
distal
ileum
mln
figur
despit
protect
effect
sera
vaccin
age
mice
significantli
lower
antimnv
igg
compar
adult
mice
figur
data
indic
protect
mnv
infect
occur
absenc
robust
serolog
respons
rais
possibl
cell
play
fundament
import
role
vaccin
mnv
next
determin
whether
protect
confer
mnv
vrp
long
live
wt
mice
prime
boost
shown
figur
mnv
vrp
mice
challeng
two
four
week
later
mnv
titer
measur
three
day
postchalleng
two
week
postboost
observ
complet
protect
ileal
infect
vaccin
either
p
vrp
compar
reoviru
ha
vrp
control
figur
two
week
vaccin
either
vrp
limit
replic
mln
live
viru
vaccin
effect
figur
live
viru
vaccin
confer
full
protect
replic
distal
ileum
mln
four
week
vaccin
boost
vaccin
vrp
also
protect
albeit
less
effect
vaccin
figur
thu
live
viru
subunit
vaccin
induc
longterm
protect
mnv
infect
live
viru
vaccin
provid
complet
protect
next
determin
mechan
respons
effect
vaccin
vaccin
mice
lack
major
histocompat
complex
mhc
class
microglobulin
cell
defici
mhc
class
ii
cell
defici
b
cell
defici
mice
figur
experi
conduct
concurr
experi
figur
data
wt
mice
repeat
figur
comparison
live
mnv
vaccin
induc
signific
protect
mnv
challeng
distal
ileum
mln
b
cell
mhc
class
iiand
mhc
class
case
figur
howev
consider
variat
efficaci
vaccin
distal
ileum
mln
differ
immunodefici
strain
b
cellmic
vaccin
live
viru
mice
titer
two
mice
less
pfu
mnv
mhc
class
similar
vaccin
led
undetect
viral
titer
distal
ileum
figur
detect
titer
mln
figur
mhc
class
iimic
detect
titer
tissu
figur
result
vaccin
show
protect
requir
activ
major
aspect
adapt
immun
respons
figur
moreov
protect
elicit
vaccin
either
intestin
mln
tissu
vaccin
mhc
class
vrp
figur
indic
protect
vrp
critic
depend
cell
data
demonstr
complet
protect
tissu
vaccin
live
viru
requir
concert
action
b
cell
mhc
class
ii
mhc
class
result
consist
tissu
specif
role
b
cell
cell
cell
develop
complet
protect
mnv
infect
next
determin
whether
cell
type
requir
vaccin
also
requir
effici
clearanc
acut
infect
focus
role
cell
clearanc
sinc
role
b
cell
clearanc
alreadi
demonstr
determin
role
cell
clearanc
acut
mnv
infect
inocul
wt
mhc
class
ii
mhc
class
oral
measur
viral
titer
distal
ileum
mln
three
five
seven
day
postinfect
figur
signific
differ
viral
titer
mhc
class
wt
mice
three
five
day
postinfect
indic
mhc
class
requir
mnv
infect
earli
time
point
figur
iicompar
wt
mice
seven
day
postinfect
p
figur
eight
day
postinfect
mln
infect
clear
togeth
data
indic
mhc
class
ii
infer
cell
necessari
control
acut
mnv
infect
requir
eventu
clearanc
mnv
infect
exclud
possibl
phenotyp
observ
mhc
class
mhc
class
iimic
due
abnorm
immun
ontogeni
knockout
mice
determin
requir
cell
clearanc
primari
mnv
infect
wt
mice
deplet
cell
deplet
cell
least
effect
assess
flow
cytometri
isol
splenocyt
figur
deplet
protocol
effect
deplet
cell
secondari
lymphoid
organ
intestin
comparison
control
antibodi
deplet
cell
led
signific
increas
mnv
titer
distal
ileum
p
figur
mln
figur
contrast
deplet
cell
led
increas
mnv
titer
distal
ileum
p
figur
mln
p
figur
togeth
data
primari
challeng
nonimmun
mice
lack
antigen
present
molecul
deplet
specif
cell
subset
demonstr
cell
import
effici
mnv
clearanc
distal
ileum
especi
day
three
next
determin
whether
cell
vaccin
mice
alon
combin
clear
mnv
infect
mucos
site
previous
shown
mnv
infect
high
level
viral
rna
present
multipl
tissu
day
postinfect
therefor
determin
mnv
viral
titer
day
postinfect
consist
high
level
mnv
duodenumjejunum
distal
ileum
figur
well
sever
tissu
data
shown
data
confirm
mice
lack
adapt
immun
fail
clear
mnv
infect
avail
persist
infect
allow
us
determin
role
cell
clearanc
mnv
infect
use
adopt
transfer
splenocyt
mnv
immun
wt
mice
persist
infect
transfer
immun
nonimmun
splenocyt
signifi
defin
cell
requir
mnv
clearanc
cell
deplet
splenocyt
transfer
antit
cell
antibodi
effect
deplet
appropri
cell
popul
measur
six
day
posttransf
flow
cytometri
figur
deplet
either
cell
individu
led
signific
increas
mnv
titer
duodenumjejunum
compar
control
deplet
figur
deplet
p
deplet
p
deplet
cell
transfer
immun
splenocyt
caus
signific
addit
increas
mnv
titer
compar
either
deplet
alon
p
deplet
alon
p
distal
ileum
deplet
either
cell
p
cell
led
signific
increas
mnv
titer
figur
data
demonstr
immun
cell
necessari
clearanc
persist
mnv
infect
intestin
two
major
effector
mechan
antivir
effect
cell
product
ifnc
perforin
mediat
cytolysi
therefor
adopt
transfer
immun
splenocyt
ifncor
perforinmic
persist
infect
determin
capac
clear
intestin
mnv
infect
immun
splenocyt
ifncmic
effect
wt
mice
figur
howev
immun
splenocyt
perforinmic
less
effect
clear
mnv
infect
duodenumjejunum
p
figur
distal
ileum
p
figur
cell
either
wt
ifncmic
effect
compar
transfer
nonimmun
cell
duodenumjejunum
p
distal
ileum
p
thu
perforin
critic
effici
clearanc
mnv
infect
intestin
relev
effector
mechan
paper
defin
mechan
immun
noroviru
infect
measur
vaccin
clearanc
mucos
infect
found
possibl
gener
highli
effect
remark
long
last
immun
noroviru
infect
oral
exposur
live
viru
system
exposur
viral
capsid
protein
express
vaccin
vector
result
effect
immun
albeit
effect
observ
live
viru
vaccin
importantli
show
mnv
protein
contain
relev
b
cell
cell
cell
epitop
vaccin
effect
age
mice
addit
vaccin
adult
mice
requir
concert
action
cell
cell
b
cell
complet
protect
tissu
survey
interestingli
activ
differ
compon
adapt
immun
system
clearanc
vaccin
tissu
specif
differ
cell
play
role
intestin
compar
drain
lymph
node
perforin
import
effector
molecul
data
import
implic
understand
adapt
immun
anim
noroviru
repres
genu
caus
signific
diseas
human
hunv
infect
diseas
rapid
symptom
develop
within
hour
infect
last
day
thu
select
three
day
challeng
readout
infect
studi
sinc
relev
vaccinegener
immun
respons
would
act
earli
challeng
lack
three
compon
adapt
respons
b
cell
cell
cell
significantli
diminish
vaccin
effect
gener
either
live
viru
capsid
protein
immun
delay
viral
clearanc
primari
infect
indic
antibodi
epitop
well
mhc
restrict
cell
epitop
data
suggest
may
necessari
engag
concert
action
intact
immun
respons
includ
mhc
class
mhc
class
ii
restrict
cell
antibodi
respons
effici
vaccin
hunv
infect
protect
mnv
infect
age
mice
absenc
robust
gener
antimnv
antibodi
rais
possibl
import
compon
vaccin
respons
cell
depend
hypothesi
born
adopt
transfer
studi
importantli
antivir
effector
perforin
import
clearanc
mnv
intestin
suggest
cytotox
cell
respons
key
effector
mechan
possibl
cell
type
nk
cell
might
also
use
perforin
mechan
control
mnv
infect
data
rule
role
ifnc
clearanc
mnv
infect
sinc
nk
cell
recipi
make
ifnc
suggest
cell
deriv
ifnc
play
minor
role
effector
cell
function
ileum
argu
classic
ctl
assay
may
good
surrog
develop
effect
vaccinegener
immun
respons
hunv
live
viru
vaccin
effect
vrp
base
vaccin
lower
level
protect
observ
vrp
contrast
may
due
mani
factor
studi
provid
mechanist
insight
differ
comparison
vlp
vrp
may
advantag
system
vaccin
includ
target
dendrit
cell
intrins
adjuv
activ
properti
vrp
may
respons
effect
system
singl
protein
subunit
vaccin
mucos
viral
challeng
case
howev
may
vrp
undergo
singl
round
replic
site
inocul
gener
breadth
immun
gener
live
replic
viru
vrp
vaccin
clearli
induc
relev
effector
memori
cell
respons
vaccin
capsid
alon
may
suffici
gener
complet
antigen
repertoir
requir
effect
immun
interestingli
found
protect
nonstructur
polyprotein
suggest
protect
epitop
exist
outsid
capsid
protein
polyprotein
express
earli
infect
may
epitop
would
valuabl
target
gener
effici
immun
respons
note
vaccin
via
subcutan
rout
provid
signific
protect
despit
fact
vaccin
occur
system
protect
read
mucos
site
indic
activ
system
immun
respons
provid
protect
noroviru
infect
mucos
vaccin
may
necessari
vaccin
noroviru
infect
importantli
system
vaccin
depend
cell
indic
relev
cell
traffic
intestin
peripher
vrpbase
vaccin
studi
leav
sever
import
question
unansw
firstli
use
homolog
viru
challeng
natur
like
host
repeatedli
challeng
antigen
distinct
norovirus
howev
mous
noroviru
strain
identifi
far
fall
singl
genogroup
gv
like
repres
singl
serotyp
way
murin
norovirus
identifi
date
may
present
less
challeng
immun
system
hunv
distribut
across
genogroup
appear
evolv
antibodi
select
addit
select
strain
mnv
clear
wt
mice
strain
persist
prolong
period
day
remain
determin
whether
vaccin
effect
persist
mnv
strain
interest
human
norovirus
persist
beyond
time
frame
usual
clinic
symptom
longterm
persist
might
contribut
explain
sporad
epidem
infect
absenc
anim
reservoir
antigen
pathogenet
complex
like
major
issu
develop
noroviru
vaccin
lack
compar
variat
mnv
strain
limit
util
mnv
model
assess
immun
antigen
distinct
strain
perhap
limit
overcom
addit
strain
mnv
identifi
sequenc
studi
howev
fact
observ
partial
cross
protect
mnv
one
hunv
demonstr
vaccin
mani
differ
vlp
enhanc
gener
cross
reactiv
antibodi
provid
encourag
two
way
murin
noroviru
infect
may
repres
biolog
hunv
infect
first
lack
diarrhea
mice
infect
strain
mnv
use
possibl
adapt
respons
clear
mnv
intestin
demonstr
irrelev
respons
may
prevent
human
diseas
regard
import
note
studi
adult
mice
rotavirus
also
infect
model
import
consider
rotaviru
vaccin
importantli
human
studi
may
reveal
mechan
effect
immun
base
surrog
assay
immun
sinc
invas
sampl
tissu
may
technic
difficult
studi
piglet
may
reveal
sinc
piglet
develop
diarrhea
infect
hunv
strain
howev
difficult
studi
immun
mechan
system
thu
left
sever
imperfect
system
consid
one
seek
hunv
vaccin
studi
mice
argu
vaccin
induc
aspect
adapt
immun
respons
assay
cytotox
lymphocyt
respons
hunv
infect
may
import
surrog
assay
protect
second
aspect
murin
noroviru
infect
unknown
relev
human
infect
impress
capac
mnv
infect
lymph
node
drain
intestin
paper
may
relat
tropism
mnv
dendrit
cell
macrophag
like
reflect
spread
mnv
directli
intestin
may
also
reflect
seed
mln
system
site
consid
distal
ileum
alon
b
cell
mhc
class
requir
live
viru
vaccin
signific
incomplet
protect
mhc
class
iimic
figur
consist
studi
primari
clearanc
show
singl
arm
adapt
respons
dispens
ultim
control
primari
infect
intestin
howev
vaccinationmedi
control
infect
mln
clearanc
primari
infect
mln
requir
b
cell
differenti
requir
compon
immun
respons
differ
organ
rais
import
question
noroviru
pathogenesi
lymphoid
infect
cell
infect
intestin
mln
differ
viral
tropism
two
tissu
might
explain
differenti
requir
b
cell
ileum
mln
indic
import
futur
studi
role
immun
noroviru
cell
organ
tropism
virus
viral
stock
vrp
plaqu
assay
mnv
strain
use
viru
infect
two
mutat
result
chang
encod
amino
acid
distinguish
genom
gener
concentr
viru
stock
raw
cell
atcc
manassa
va
infect
vpsfm
media
gibco
carlsbad
ca
day
multipl
infect
moi
supernat
clarifi
lowspe
centrifug
min
rpm
viru
concentr
centrifug
h
rpm
g
rotor
viral
pellet
resuspend
pb
titer
raw
cell
previous
describ
type
lang
reoviru
kindli
provid
dr
terrenc
dermodi
vanderbilt
univers
nashvil
tn
plaqu
assay
perform
previous
describ
follow
modif
tissu
harvest
steril
screwtop
tube
contain
ml
zirconiasilica
bead
biospec
product
bartlesvil
ok
store
obtain
viral
titer
tissu
ml
complet
dmem
ad
sampl
ice
homogen
use
magna
lyser
roch
appli
scienc
hagu
road
prior
plaqu
assay
limit
detect
plaqu
form
unit
pfu
ml
vrp
produc
previous
describ
briefli
orf
lordsdal
viru
chiba
viru
clone
vrp
express
vector
follow
infect
bhk
cell
vrp
h
cultur
supernat
harvest
cell
lyse
protein
separ
sdspage
analyz
western
blot
polyclon
rabbit
antimnv
serum
vrp
titer
effici
express
recombin
protein
determin
immunofluoresc
assay
use
mous
antisera
gener
inocul
respect
antigen
cell
lysat
mnv
chiba
viru
lordsdal
viru
vrpinfect
cell
cultur
purifi
obtain
vlp
raw
cell
maintain
previous
describ
monoclon
antibodi
mab
specif
atcc
produc
hybridoma
cell
line
integra
cellin
flask
integra
bioscienc
ijamsvil
md
use
cd
hybridoma
media
gibco
carlsbad
ca
previous
describ
mice
cage
sentinel
mice
mice
defici
antibodi
product
test
elisa
presenc
mnv
antibodi
prior
experi
mice
use
studi
seroneg
initi
experi
mice
use
vaccin
studi
immun
pfu
control
type
lang
reoviru
per
oral
po
ml
dmem
contain
fetal
bovin
serum
hyclon
logan
ut
cdmem
vrp
immun
infecti
unit
iu
vrp
express
individu
group
vrp
chiba
viru
lordsdal
viru
ml
ml
volum
footpad
inocul
subcutan
space
day
boost
day
ha
vrp
pb
immun
ml
ml
volum
footpad
inocul
day
boost
day
serv
control
vrp
immun
mice
challeng
pfu
specifi
time
boost
tissu
harvest
three
day
postchalleng
control
vrp
vaccin
includ
pb
vrp
express
hemagglutinin
ha
mous
adapt
influenza
viru
pb
serv
control
ha
vrp
experi
event
ha
vrp
signific
effect
mnv
replic
ha
vrp
control
significantli
differ
pb
control
experi
present
figur
complet
splenocyt
donor
mice
infect
pfu
po
ml
cdmem
mice
infect
pfu
po
two
segment
small
intestin
harvest
one
inch
section
small
intestin
immedi
distal
pyloru
stomach
design
duodenumjejunum
one
inch
section
small
intestin
immedi
proxim
cecum
design
distal
ileum
mice
distal
ileum
three
mesenter
lymph
node
mln
harvest
except
inocul
week
age
age
wt
mice
inocul
month
age
mice
inocul
week
age
spleen
harvest
mice
singl
cell
suspens
gener
cell
count
dilut
media
sigma
saint
loui
mo
supplement
fetal
calf
serum
hyclon
logan
ut
u
penicillinml
mgml
streptomycin
mm
hepe
acid
sodium
pyruv
mm
mm
lglutamin
crpmi
adopt
transfer
experi
cell
inject
persist
infect
intraperiton
ip
inject
crpmi
deplet
wt
mice
mg
lymphocytedeplet
antibodi
isotypematch
control
antibodi
administ
ip
one
day
prior
one
day
infect
deplet
adopt
transfer
experi
deplet
antibodi
administ
describ
one
dose
one
day
prior
splenocyt
transfer
second
dose
day
trnsfer
efficaci
lymphocyt
deplet
set
deplet
experi
monitor
flow
cytometr
analysi
splenocyt
end
experi
elisa
detect
bind
polyclon
antiserum
fecal
extractderiv
antibodi
purifi
mnv
virion
mnv
vlp
perform
previous
describ
data
analyz
use
graphpad
prism
softwar
graphpad
softwar
san
diego
ca
viral
titer
data
analyz
nonparametr
mannwhitney
test
differ
specif
state
signific
insignific
